Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, nominal value (euro)0.12 per share
-
Shares outstanding
-
67,811,197
-
Total 13F shares
-
8,876,969
-
Share change
-
-2,109,784
-
Total reported value
-
$22,991,081
-
Put/Call ratio
-
42%
-
Price per share
-
$2.59
-
Number of holders
-
32
-
Value change
-
-$5,612,273
-
Number of buys
-
10
-
Number of sells
-
17
Institutional Holders of InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) as of Q3 2021
As of 30 Sep 2021,
InflaRx N.V. - Common Shares, nominal value (euro)0.12 per share (IFRX) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,876,969 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, MORGAN STANLEY, Ikarian Capital, LLC, DAFNA Capital Management LLC, GREAT POINT PARTNERS LLC, Laurion Capital Management LP, KINGDON CAPITAL MANAGEMENT, L.L.C., FNY Investment Advisers, LLC, and Bank Julius Baer & Co. Ltd, Zurich.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.